Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Renal Function Test Market Outlook 2023 to 2033

The global market revenue for the renal function test market is anticipated to reach US$ 1,494.1 million by 2033, with a 5.5% CAGR during the forecast period. As of 2023, the renal function test market is valued at US$ 871.3 million.

Key Market Highlights

Growing Prevalence of Diabetes and Hypertension Boosts Renal Function Test Market

Renal function test refers to a series of blood and urine tests that help doctors understand the condition of patients' kidneys. In these few decades, cardiovascular disease has tremendously increased due to a passive lifestyle, alcohol abuse, and unhealthy eating habits. These diseases are the leading causes of chronic kidney diseases, which require regular monitoring of kidney functions, which is done by renal function tests.

According to the World Health Organization, around 422 million people worldwide have diabetes, and more than one billion people suffer from problems related to hypertension. As these numbers continue and are expected to grow, a rising demand for renal function tests can be seen in the upcoming years.

Digital Urinalysis at Home to Contribute Significantly to Kidney Assessment Tests

Advancements in renal function test technologies have enabled patients suffering from chronic kidney disease (CKD) to take regular tests at home. This technology may simplify the process and drive more revenue globally for the renal function test market.

Patients can now cut long lines and hefty consultation fees in public hospitals. The test results can even be accessed by the concerned medical practitioner, who can assess and proceed further with the treatment.

Attributes Key Statistics
Expected Base Year Value (2023) US$ 871.3 million
Anticipated Forecast Value (2033) US$ 1,494.1 million
Estimated Growth (2023 to 2033) 5.5% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Comparison of the Renal Function Test Market with the Forecast Period

The market recorded a growth of 5.7% from 2017 to 2022 due to the increased risk of kidney diseases among the aging population. The market registered a valuation of US$ 623.6 million in 2017 and reached US$ 824.2 million in 2022.

Attributes Key Statistics
Expected Base Year Value (2017) US$ 623.6 million
Anticipated Forecast Value (2022) US$ 842.2 million
Estimated Growth (2017 to 2022) 5.7% CAGR

When it comes to age, older people are more likely to undergo renal function tests as they require frequent testing due to the increased risk of kidney diseases. There are relatively few cases of kidney assessments being done on newborn babies and young children.

Availability and accessibility are crucial in the renal function test market. Areas with medium to low medical facilities showcase have very little influence on the market, while regions with highly advanced medical facilities are likely to have higher consumption rates of renal function tests. These factors led to the growth of RFT in the historical period.

Gender-wise, it has been observed that males contribute significantly to the renal function test market, mainly due to their association with an unhealthy lifestyle. Moreover, the growth of telemedicine services like digital urinalysis has increased awareness regarding preventive health care measures. Thus, the demand for renal function tests has surged remarkably.

Factors Driving the Expansion of the Renal Function Test Market

  • Soaring CKD cases: Chronic kidney diseases (CKD) have been the key root cause of kidney disorders, including complete kidney failure. As more people are at risk of kidney problems, the demand for renal function tests is also growing.
  • Aging Population: The aging population in countries with a very high-density population is always under the radar of chronic kidney diseases. These individuals require intense care and regular assessment of their kidney functionalities, leading to a higher demand for renal function tests.
  • Technological Advancements: Continuous scientific breakthroughs in medical technology have led to simpler, faster, and more accurate renal function test results. This eventually resulted in more people trusting the test results, expanding the global market size.
  • Personal Care: Due to a better understanding of personal health care and necessary preventive measures, a large chunk of the global population undergoes regular body check-ups, which include renal function tests.
  • Health Care Programs: Recent years have seen a notable rise in health initiatives both in the public and private sectors. Medical camps, which include full body check-ups, are being conducted regularly. Government-sponsored medical camps also have decent participation in the growth of the renal function test market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Factors Adversely Affecting the Renal Function Test Market

  • Expensive Costs: Renal function tests can be expensive if not covered by insurance. As these tests must be done regularly, patients with low-income sources may need help to afford testing costs. Although, these prices could be higher in government-aided hospitals, long waiting lines and lower reliability of the results are some main reasons people are reluctant to visit these facilities for renal function tests.
  • Lack of Awareness: There needs to be more awareness regarding kidney health and the significance of the same. Limited health literacy in underdeveloped regions of the world can be a key factor in the negligence of renal health and, thus, renal function tests.
  • Asymptomatic Nature: Most kidney diseases can be asymptomatic in their initial stages. Without visible symptoms, there are very few chances that individuals may consider choosing renal function tests. This can result in delayed or missed opportunities to detect CKDs while they can be easily diagnosed.
  • Government Negligence: Government policies are very detrimental in promoting preventive health care programs. Inadequate emphasis on diseases related to kidneys is one of the main reasons for the need for more awareness regarding renal function tests.
  • Insurance Coverage: Individuals may be deterred from seeking testing if they have to bear the costs of it regularly. Even individuals with insurance coverage may refrain from taking regular tests due to the non-inclusion of renal function tests. This may affect the renal function test market in the long term.

Comparative Analysis of the Adjacent Market

Future Market Insights (FMI) has compared two other markets, the cystatin C testing market and the urine monitoring systems market. The tables showcase each market’s estimated growth performance from 2023 to 2033. It highlights that the urine monitoring systems market is expanding at a higher CAGR than the other two. However, the renal function test market signifies a greater revenue potential over the other mentioned markets.

Renal Function Test Market:

Attributes Renal Function Test Market
CAGR (2023 to 2033) 5.5% CAGR
Market Value (2023) US$ 871.3 million
Growth Factors
  • The growing prevalence of cardiovascular diseases leads to CKD in adults.
  • Rising awareness of health literacy in individuals about preventive care.
Future Opportunities
  • Medical institutions should collaborate with government bodies to promote kidney health screening campaigns extensively.
  • Key players can invest in research and development activities for efficient kidney assessment tools.

Cystatin C Testing Market:

Attributes Cystatin C Testing Market
CAGR (2022 to 2032) 7.5% CAGR
Market Value (2021) US$ 194.3 million
Growth Factors
  • Rise in the cases of several disorders, such as myocardial infarction and muscular dystrophy.
  • Growth in pathology laboratories, hospital laboratories, research labs, and diagnostic centers across the geographies.
Future Opportunities
  • Countries growing rapidly also present opportunities for testing facilities due to improving healthcare infrastructure.
  • Integration of cystatin C with digital platforms can play a very crucial role in making the process more feasible.

Urine Monitoring Systems Market:

Attributes Urine Monitoring Systems Market
CAGR (2023 to 2033) 9.2% CAGR
Market Value (2023) US$ 571.55 million
Growth Factors
  • The demand for minimally invasive and effective systems to monitor patients’ urine output in neonatal care units.
  • The rising adoption of the urine monitoring systems market by hospitals and specialty clinics
Future Opportunities
  • There is a great scope for investments in specialty clinical stores that cater to problems related only to renal disorders.
  • Specialty clinical laboratories can also fetch funds from international health organizations to provide services in underdeveloped regions.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Outlook

Urinalysis for Kidney Function Using Dipsticks Continues to be Essential for Renal Health Care

Category-wise, the renal function test market is divided into dipsticks, disposables, and reagents. The dipstick renal function test, which dominates the segment with a revenue share of 57.4%, is a simple and very commonly used renal test to monitor kidney functions. It is the most commonly used renal test and is considered to provide quick results, sometimes within minutes after the test.

Attributes Details
By Product Type Dipsticks
Market share 57.4%

While renal function tests are often regarded as cost-intensive, urinalysis using dipsticks is generally more affordable and more accessible to the general population. These tests are very simple, making them very reassuring for patients who avoid long medical procedures. The infrastructure requirements for dipstick renal function tests are minimal and can be set up with a meager investment.

A renal function test using a dipstick can be the first step in assessing the overall functionality of the kidneys. Apart from kidneys, they also provide very brief information about urinal health and the amount of certain essential nutrients in the blood. Although dipstick renal tests help medical practitioners understand the overall renal information, the results are only nominal and not very precise.

Medical Practitioners Show a Lot of Reliability in Urine-based Renal Tests

Urine-based renal examinations are the most common practice used by the majority of laboratories, as they are trusted to be the most reliable test to assess urinal health. It holds a global market share of 62.4% and is found to provide quick results at affordable prices.

Attributes Details
By Test Type Urine
Market share 62.4%

These tests are recommended as a regular practice and are not just limited to renal health but also consist of the functionality of the urinary tract, kidneys, and other excretory organs. Urine-based tests don't require drawing blood from the patient's body parts, making this a preferable choice for individuals intimidated by syringes and blood.

It's the easiest way to collect samples; patients can do that alone. Urine-based tests can be easily incorporated into routine check-ups. The ease of sample collection, simple setup, and broad spectrum of information can help urine-based renal tests gain impetus in the upcoming years.

Hospitals are a Preferred Destination for Renal Function Tests

The renal function test market is segmented by end-use into hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and home care settings. As hospitals provide more holistic care in terms of renal tests, they dominate this segment by holding a global market share of 50.6%.

Attributes Details
By End User Hospitals and Clinics
Market share 50.6%

Hospitals are packed with modern medical facilities and skilled lab technicians who can conduct simultaneous tests in the same vicinity. This makes conducting complex medicinal examinations like renal function tests very feasible. Hospitals can also provide in-house treatment facilities for patients requiring inpatient care and monitoring.

Region-wise Outlook

North America Showcases Significant Cases of Renal Disorders in 2022

Passive urban lifestyles with little to no exercise, alcohol abuse, and unhealthy eating habits contribute to kidney dysfunction. According to a survey conducted by Future Market Insights, the North American renal function testing market recorded a market share of 34.3% in 2022.

Region North America
Value Share in 2022 34.3%

As one in three individuals living in this belt has diabetes, the possibility of them getting diagnosed with CKD is very high. As individuals with chronic kidney disorders require intense care and monitoring of their renal health, the demand for such facilities is touching the skies in this region.

The European Region Becomes the Topmost Contributor to the Global Renal Function Test Market

Technological advancements in the medical facilities of several European countries have largely contributed to the growth of the global renal function market. Of the total market, Europe holds a market share of 29.8%.

Region Europe
Value Share in 2022 29.8%

Government initiatives coupled with health-literate residents are some of the main factors in this promising market size. For instance, Atlas Medical, a diagnostic kit manufacturer based in the United Kingdom, introduced products in blood grouping reagents, urine reagent strips, latex kits, and other home test kits.

Country-wise Insights

Kidney Diseases Becomes the Leading Cause of Death in the United States

According to the Centers for Disease Control, more than 37 million citizens of the United States have chronic kidney disorders; it is estimated that 90% of them don't even know they have it. The government bodies' CKD Initiative is shaped to collaborate with the leading hospitals, colleges, and national organizations to promote early diagnosis and reduce the risk factors by detecting the symptoms in the initial stages of the disorder.

Country The United States
Value Share in 2022 28.8%

Growing Population in China Fuel Renal Function Test Market Expansion

The increasing geriatric population coupled with highly affluent residents makes China one of the most influential markets in renal function tests. As a country with a huge population, the demand for renal function tests may drastically boost the market size. Like most developed countries, the Chinese government has made huge investments in the research and promotion of CKDs.

Country China
Value Share in 2022 7.4%

Competitive Landscape in Renal Function Test Market

Many start-up and established companies are bringing innovative medical devices that can ease the process of urine and blood tests to check the health of kidneys.

Several visionaries are at the forefront of delivering accurate results while maintaining transparency. F. Hoffmann-La Roche Ltd., Nova Biomedical, Quest Diagnostics, and ACON Laboratories are some business leaders dominating the renal function test market.

Recent Developments in the Renal Function Test Market

  • In June 2023, Boditech Med and SphingoTec signed a market development agreement regarding further developing their flagship kidney function biomarker, penKid. penKid is a medical technology that provides precise renal information in renal replacement therapies.
  • In August 2022, Bloom Diagnostics, a Swiss medtech company, launched a new test designed to rapidly measure and quantify kidney function in users 18 years of age and older.
  • In June 2023, IDEXX Laboratories launched its first-of-a-kind renal function test for pet animals such as cats and dogs. This new technology can be a boon for veterinary professionals to detect renal abnormalities in their initial stages.

Key Companies in the Market

  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Beckman Coulter (Danaher)
  • Abbott Laboratories Baxter International
  • Quest Diagnostic Incorporated
  • Sysmex Corporation
  • Laboratory Corporation of America Holdings (LabCorp)
  • Randox Laboratories
  • ACON Laboratories
  • Arkray
  • Nova Biomedical
  • Idexx Laboratories
  • Opti Medicals
  • Elektronika
  • Cook Medical
  • VedaLab
  • Dx Gern Corp

Key Segments Covered in Renal Function Test Market Report

By Product Type:

  • Dipsticks
  • Disposable
  • Reagents

By Test Type:

  • Urine
  • Blood Test

By End User:

  • Hospitals and Clinics Diagnostic laboratories
  • Research Laboratories and Institutes
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Renal Function Test Market?

The current market valuation of renal function tests is likely to be US$ 871.3 million.

Which Region is Forecast to be Lucrative for Renal Function Test Market?

North America is expected to accumulate 34.3% of the market share in 2022.

What is the Market Potential for Renal Function Tests by 2033?

The renal function test market is expected to reach US$ 1,494.1 million

Which Test Type is Widely Preferred in the Market?

Urine-based renal tests are the widely preferred segment.

How was the Historical Performance of the Market?

The market recorded a valuation of US$ 824.2 million in 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Dipsticks

        5.3.2. Disposable

        5.3.3. Reagents

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033

        6.3.1. Urine Test

            6.3.1.1. Urine Protein

            6.3.1.2. Microalbumin

            6.3.1.3. Creatinine Clearance

        6.3.2. Blood Test

            6.3.2.1. Serum Creatinine

            6.3.2.2. GFR rate

            6.3.2.3. Blood Urea Nitrogen (BUN)

    6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033

        7.3.1. Hospitals and Clinics

        7.3.2. Diagnostic laboratories

        7.3.3. Research Laboratories and Institutes

        7.3.4. Home Care Settings

    7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Test Type

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Test Type

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Test Type

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Test Type

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Test Type

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Test Type

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Test Type

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Test Type

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product Type

        13.2.3. By Test Type

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Test Type

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product Type

        14.2.3. By Test Type

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Test Type

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Test Type

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Test Type

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Test Type

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Test Type

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Test Type

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Test Type

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Test Type

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Test Type

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Test Type

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Test Type

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Test Type

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Test Type

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Test Type

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Test Type

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Test Type

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Test Type

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Test Type

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Test Type

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Test Type

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Test Type

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Test Type

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Test Type

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Test Type

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Test Type

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product Type

            16.23.2.2. By Test Type

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Test Type

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. F. Hoffmann-La Roche Ltd.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Siemens Healthineers

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Beckman Coulter (Danaher)

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Abbott Laboratories

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Baxter International

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Quest Diagnostic Incorporated

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Sysmex Corporation

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Laboratory Corporation of America Holdings (LabCorp)

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Randox Laboratories

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. ACON Laboratories

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. Arkray

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. Nova Biomedical

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Idexx Laboratories

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

        18.1.14. Opti Medicals

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

        18.1.15. Elektronika

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

        18.1.16. Cook Medical

            18.1.16.1. Overview

            18.1.16.2. Product Portfolio

            18.1.16.3. Profitability by Market Segments

            18.1.16.4. Sales Footprint

            18.1.16.5. Strategy Overview

                18.1.16.5.1. Marketing Strategy

        18.1.17. VedaLab

            18.1.17.1. Overview

            18.1.17.2. Product Portfolio

            18.1.17.3. Profitability by Market Segments

            18.1.17.4. Sales Footprint

            18.1.17.5. Strategy Overview

                18.1.17.5.1. Marketing Strategy

        18.1.18. Dx Gern Corp

            18.1.18.1. Overview

            18.1.18.2. Product Portfolio

            18.1.18.3. Profitability by Market Segments

            18.1.18.4. Sales Footprint

            18.1.18.5. Strategy Overview

                18.1.18.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Urine Monitoring Systems Market

Published : March 2023

Healthcare

Kidney Stone Extraction Balloon Market

Published : July 2022

Healthcare

Acute Kidney Injury Treatment Market

Published : July 2022

Explore Healthcare Insights

View Reports

Renal Function Test Market